Biochemically Controlled Acromegaly Patients on a Stable Dose of Injectable Somatostatin Analogues (SSAs) in Routine Clinical Practice Still Remain Symptomatic: Preliminary Results from Endocrinology Health Care Professionals

Relationship between Responses from Acromegaly Patients Treated with a Stable Dose of Injectable Somatostatin Analogues in Routine Clinical Practice and their Endocrinology Health Care Professional regarding treatment Outcomes: Preliminary Findings

This poster summarizes findings specifically among physicians treating ‘well-controlled’ patients, who they reported still experienced significant treatment burden and active acromegaly-related symptoms despite being considered biochemically well-controlled.

Biochemically Controlled Acromegaly Patients on a Stable Dose of Injectable Somatostatin Analogues (SSAs) in Routine Clinical Practice Still Remain Symptomatic: Preliminary Results from Endocrinology Health Care Professionals (Geer E., Sisco J., Adelman D., Ludlam W., Haviv A., Gelbaum D., Liu S., Mathias S., Shi L.; 2019)